Effectiveness of Digital Commitment Devices in Improving Lifestyle and Cardiometabolic Outcomes in Adults with Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis

Clicks: 26
ID: 334078
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #128 of 288 articles by views in european journal of preventive cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 288 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
AIM: Lifestyle modification is crucial for cardiovascular disease prevention but remains challenging due to complex behavioural factors such as the intention-behaviour gap. Digital commitment devices (DCD) could narrow this gap by leveraging behavioural economics, but its effectiveness remains unclear. Therefore, this review aims to evaluate the effects of DCDs on lifestyle and cardiometabolic outcomes in adults with elevated cardiometabolic risk. METHODS: A systematic search of 12 electronic databases was conducted from database inception to August 2025. Study selection and methodological quality appraisal using the Cochrane Risk of Bias 2.0 tool were performed independently by two reviewers. Where appropriate, effect sizes were pooled using random effects meta-analyses. The certainty of evidence for meta-analysed outcomes was assessed using the GRADE approach. RESULTS: A total of 7,378 articles were retrieved, of which 29 randomised controlled trials involving 7,534 participants were included. DCDs were found to significantly increase daily step count (WMD=664.87, 95% CI: 463.22 to 866.51, T=6.88, p<0.00001; I2=0%) and weight loss (WMD=-1.90kg, 95% CI: -2.59 to -1.21, p<0.0001; I2=70%), improve self-reported emotional (WMD=-1.34, 95% CI: -2.59 to -0.09, p=0.04; I2=0%) and uncontrolled eating (WMD=-1.74, 95% CI: -3.05 to -0.43, p=0.02; I2=0%) behaviours, body fat percentage, diet and medication adherence. CONCLUSION: DCDs could improve lifestyle and cardiometabolic outcomes by improving physical activity and weight management, thus enhancing cardiometabolic disease prevention. Future research should prioritise long-term trials with extended follow-up periods beyond 12 months to observe physiological improvements and assess maintenance of effects.
Reference Key
openalex_W7223669299 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal european journal of preventive cardiology
Year 2026
DOI
10.1093/eurjpc/zwag534
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.